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Abstract
BACKGROUND: Drug-induced kidney disorder is a frequent adverse event which contributes to morbidity and even 
incapacitation. Our current knowledge of drug-induced kidney disease is limited due to varying definitions of kidney 
injury, incomplete assessment of concurrent risk factors, and lack of long term outcome reporting. 
AIM: The discovery and development of novel biomarkers and local (renal) response mechanisms, which can 
diagnose kidney damage earlier and more accurately, are needed for effective prevention of drug-induced 
nephrotoxicity.
METHODS: Forty patients from 22 to 50 years old with drug-induced nephropathy (43 females, 27 males) were 
included in the study. The determination of oxidative stress modifications as advanced oxidation protein products 
(AOPPs), protein reactive carbonyl derivatives (PRCD), methylglyoxal, and catalase (CAT) level were assayed. 
AOPP was rated in blood plasma through the Witko-Sarsat (1996) method, PRCD by Levine (2000) method, 
methylglyoxal through the Racker (1963) method, CAT was evaluated with Koroljuk (1988) and Aebi (1984) methods. 
Conditionally, 30 healthy-matched persons were included in the control group.
RESULTS: In psychotropic and nonsteroidal anti-inflammatory drugs (NSAID) drug-induced nephropathy patients, 
there was a tendency to increase the concentration of AOPP in blood plasma, PRCD, and methylglyoxal in 
erythrocytes relative to the upper limits of normal ranges. Moreover, there was a significant decrease of the CAT 
level in blood plasma relative to the upper limits of normal ranges.
CONCLUSION: Thus, the results of the present study permit us to draw the following conclusions. The patients with 
psychotropic and NSAIDs drug-induced nephropathy have increased level of oxidative stress products and increased 
neutrophil gelatinase-associated lipocalin level even in normal eGFR. The mechanisms that lead to the development 
of oxidative stress and the production of modified proteins are different in patients treated with different drugs.
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Introduction
In recent years, the number of medicinal lesions 
of the kidneys has become much more frequent in the 
practice of doctors of all specialties [1]. The reason is 
the continuous expansion of the medicines arsenal. 
Any drug may have potential nephrotoxicity. Drugs can 
cause damage with prolonged and uncontrolled use.
Approximately 20% of nephrotoxicity is induced 
by drugs [2], [3]. Medicinal lesions of the kidneys are 
one of the common causes of both acute and chronic 
nephropathy, endangering the patient’s life. For example, 
in the structure of causes of end-stage renal failure, the 
role of analgesic injury has significantly increased in the 
past 20 years [4]. Moreover, a recent large database 
analysis raised concerns of potential acute kidney injury 
(AKI) risk associated with antipsychotics [5], [6] and 
cytotoxic effect of tricyclic antidepressants [7], [8], [9].
However, the molecular mechanisms of kidney 
damage in these cases are still poorly understood. 
It is believed that one of the possible damage 
mechanisms is oxidative stress. It has recently been 
shown that oxidative stress in the kidneys underlies 
acute nephrotoxicity caused by drugs. Proteins could 
be directly modified by reactive oxygen species 
(ROS) which leads to amino acid oxidation and cross-
linking. The formation of oxidized modified proteins is 
accompanied by a loss of the protein functional activity, 
dysfunction of the conformation, the formation of 
aggregates, or fragmentation [10]. Carbonyl metabolic 
products include advanced oxidation protein products 
(AOPPs) and protein reactive carbonyl derivatives 
(PRCD) [11]. AOPPs have fairly pronounced biological 
properties similar to AGEs and can bind to the receptor 
for advanced glycation end products (RAGE) that 
lead to chronic kidney disease development [12]. Of 
particular interest is methylglyoxal one of the most 
reactive carbonyl compound, effecting on intracellular 
signaling systems [13]. One of the enzymes that play 
an important role in protecting cells against the toxic 
effects of oxidative stress is catalase (CAT). In human, 
it has been implicated in different physiological and 
pathological conditions [14].
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Such an important aspect of oxidative stress 
as oxidative modification of proteins in the case 
of exogenous toxic nephropathies, including drug 
poisoning, is practically unstudied.
Thus, the problem of drug-induced 
nephropathies (DIP) is of increasing importance due to 
the multifactorial nature of damaging agents that tend 
to grow continuously, as well as the lack of knowledge 
of systemic and local (renal) response mechanisms. 
The main purpose of our study was to investigate the 
oxidative modifications of proteins in blood plasma and 
red blood cells of patients with DIP.
Materials and Methods
This prospective cross-sectional study was 
conducted on the basis of the biochemical laboratory 
of Karaganda Medical University, together with the 
Toxicological Department of the Regional Medical 
Center (from January 2017 to February 2018). Acute 
poisoning with remedies was diagnosed, considering 
the history of drug intake, physical examination, 
according to the clinical protocol recommended 
by the Expert Council of the Ministry of Health and 
Social Development of the Republic of Kazakhstan 
(August 25, 2016). Nephropathies were diagnosed 
by nephrologist according to medical history, an 
objective examination, urine parameters (proteinuria, 
macro/microhematuria, cylindruria, and decreased 
urine relative density) and reduced eGFR. eGFR was 
calculated according to serum creatinine concentration, 
using the Chronic Kidney Disease Epidemiology Collaboration 
formula (unit in ml/min/1.73 m2), serum neutrophil 
gelatinase-associated lipocalin (NGAL) level (as a 
sensitive biomarker for the early diagnosis of AKI) [15].
Exclusion criteria were the presence of 
acute infectious and inflammatory processes of other 
organs during the study period, as well as acute or 
chronic pyelonephritis of infectious etiology, acute or 
chronic glomerulonephritis, diabetes and/or diabetic 
nephropathy, obesity, and gestational nephropathy. In 
addition, persons younger than 18 years or older than 
50 years were excluded from the study.
The study included 70 patients from 22 to 
50 years old (43 females, 27 males; mean age 31.5; 
SD: 6.3). Thirty healthy donors (control group) served 
as a comparison group.
The first group consisted of 35 patients with 
psychotropic-induced nephropathy. All the patients in 
this group had poisoned with tricyclic antidepressants 
(in 90.1% cases, it was amitriptyline) to commit suicide.
About 45.8% of patients got drugs from 
relatives with different types of psychological disorders; 
in other cases, remedies were prescribed by neurologist 
or psychotherapist to cure insomnia (24.8%) and 
depression (29.4%).
The second group included 35 patients with 
nephropathy caused by nonsteroidal anti-inflammatory 
drugs (NSAIDs). The structure of NSAID suicidal 
poisoning was distributed as follows: Acetaminophen 
(43.5%), diclofenac (22.8%) ibuprofen (16.8%), 
acetylsalicylic acid (9.3%), and ketoprofen and 
ketorolac (7.6%). All the patients had obtained NSAIDs 
easily from a retail pharmacy.
The control group was represented by 
individuals without clinical and laboratory signs of 
impaired renal function, absence of any drug intake at 
least 3 month.
Blood sampling and biochemical analysis
Blood sampling was carried out early in 
the morning on the 2nd day of hospitalization since it 
is believed that this time is enough for a response of 
serum creatinine in the case of AKI [16]. Blood was 
stabilized by heparin. All blood tests were conducted 
within 2 h after the blood collection. Serum NGAL level 
was measured using a commercially available ELISA 
kit (Affymetrix eBioscience, Vienna, Austria); the unit of 
measure was ng/ml.
Biochemical measurements were carried out 
on a PD-303 UV A PEL spectrophotometer (Japan).
AOPP was measured spectrophotometrically 
as described by Witko-Sarsat et al. [15]. Briefly, 0.35 ml 
of blood plasma and 1.75 ml of sodium/potassium buffer 
solution were placed into a spectrophotometric cuvette 
and gently mixed, then 0.2 ml of glacial acetic acid and 
0.1 ml of potassium iodide were added and measured 
at 340 nm. A mixture of buffer solution, glacial acetic 
acid, and potassium iodide served as a control. The 
concentration of oxidative products of proteins containing 
bityrosine cross-links (AOPP) was expressed in nmol/l.
PRCD was assayed in blood plasma and 
erythrocytes by the method of Stadtman and Levine [17]. 
0.1 ml of blood plasma, 0.5 ml of 20% trichloroacetic 
acid, and 0.5 ml of dinitrophenylhydrazine were added 
to the centrifuge tube. The reaction mixture is incubated 
at room temperature for 1 h and centrifuged at 3000 rpm 
for 5–7 min. Supernatant discarded. The obtained 
precipitate is resuspended in 0.5 ml of ethyl acetate and 
centrifuged at 3000 rpm for 3 min. This procedure is 
repeated 2 times. The resulting precipitate is incubated 
at 37 for 18 h. After incubation, 2 ml of urea is added to 
the precipitate and measured on a spectrophotometer 
at 370 nm. Distilled water serves as control.
Methylglyoxal was measured in blood plasma 
and erythrocytes according to the method of Racker 
et al. [16]. Twenty-five milliliters of samples were added 
to 350 ml DNPH (0.1% DNPH in 2 n. HCl). Then to each 
tube was added 2.125 ml of distilled water. It was then 
incubated for 15 min at 37°C. After incubation, 1.5 ml of 
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10% NaOH was added and the absorbance was read at 
576 nm using a spectrophotometer.
CAT activity was determined in blood plasma 
and erythrocytes, according to Korolyuk et al. [18] and 
Aeby [19]. The first tube with 1.0 ml hydrogen peroxide 
and 0.1 ml distilled water, the second tube with 1.0 ml 
distilled water and 0.1 ml blood serum, and the third 
one with 1.0 ml hydrogen peroxide and 0.1 ml blood 
serum incubated at room temperature for 10 min. Into 
all tubes was added 1.0 ml ammonium molybdate. 
The intensity of the developed color is measured on 
a spectrophotometer at λ = 410 nm against a control 
sample and expressed in Units/ml.
Statistical analysis
The program Statistica for Windows, 
version 12 was used to analyze the received data. One-
way ANOVA for independent variables was used [20] to 
determine significant differences between the groups. 
The choice of this statistical method was due to the 
normal distribution of data (Shapiro–Wilk normality 
test, p > 0.05) and homogeneity of variances (Levene’s 
test, p = 0.591) [21]. The differences were considered 
reliable at significance level p < 0.05. The post-hoc 
Bonferroni test was used to identify pairs of samples, 
differing from each other in means. Parametric data are 
presented as mean ± SD.
Ethical issue
The study was approved by the ethics 
committee of Karaganda Medical University and was 
conducted in accordance with the Helsinki Declaration. 
Informed consent was obtained from all the patients 
before their inclusion in the study. During the presence 
of patients in the toxicological department, all of them 
received standard therapy, corresponding to the 
poisoning severity and developed complications.
Results
Table 1 shows that carbonyl derivatives are 
significantly higher in red blood cells of the 1st and 
2nd group patients compared to the control subjects 
(p < 0.001). AOPP statistically increased both in 
patients with various types of drug nephropathy when 
compared with the control group. However, there were 
no significant differences of the values, depending on 
the type of DIP.
As to the serum NGAL, it is significantly higher 
in 4 times compared to the control subjects (p < 0.01). 
No correlations of NGAL with other indicators were 
found.
The 2.5 times reduction of plasma CAT 
activities (Table 2) has been observed both in the group 
with psychotropic drug-induced nephropathy and in the 
group with NSAID drug-induced nephropathy (р < 0.01). 
As to the methylglyoxal level in erythrocytes, it was 
significantly higher in both patients’ groups (р < 0.036; 
р < 0.04) compared with control.
Table 2: CAT and methylglyoxal level in patients with DIP (M±SD)
Groups Catalase Methylglyoxal
Blood 
plasma (U)
Erythrocytes 
(U)
Blood plasma 
(mg/l)
Erythrocytes 
(mg/l)
(1st group) Patients 
with psychotropic drug-
induced nephropathy
0.051 ± 0.03* 0.25 ± 0.14 0.42 ± 0.10 0.92 ± 0.12*
(2nd group) Patients with 
NSAID drug-induced 
nephropathy
0.049 ± 0.04* 0.22 ± 0.18 0.43 ± 0.11 0.90 ± 0.11*
Control subjects 0.13 ± 0.02 0.30 ± 0.16 0.34 ± 0.02 0.55 ± 0.08
NSAID: Nonsteroidal anti-inflammatory drugs, DIP: Drug-induced nephropathies.
Discussion
Our data confirm the serum NGAL elevation 
even at the stage of nephropathy formation due to the 
development of acute oxidative stress. The high level 
of the serum NGAL was showed in patients with normal 
GFR. As NGAL expression increases in proximal tubule 
cells due to drug-induced nephrotoxicity or ischemia, it 
may be considered as a sensitive biomarker for early 
diagnosis of acute kidney damage.
Safety of psychotropic drugs is nowadays 
one of the most ambiguous research problems. 
Concerns regarding the possible detrimental effect 
of psychotropic medications on kidney function are 
supported by a recent meta-analysis [3], [4]. Recently, 
several independent researchers have reported that 
psychotropic remedies exhibit a cytotoxic effect in 
human cell cultures, increasing oxidative stress.
Moreno-Fernandez et al. and Hroudova 
and Fisar [5], [6], [7], [8] showed that tricyclic 
antidepressants specifically inhibited mitochondrial 
complex III activity due to low mitochondrial 
membrane potential. The decrease of cytochrome 
C, citrate synthase, and CAT activities leads to ROS 
overproduction. This, in turn, leads to a cascade 
process of protein oxidation and glycoxidation, 
resulting in excessive production of carbonyl 
derivatives, AOPP, methylglyoxal, and AGE products. 
Table 1: PRCD, AOPP, and NGAL level in patients with DIP (M±SD)
Groups PRCD AOPP NGAL
Blood plasma 
(nmol/l)
Erythrocytes 
(nmol/l)
Blood plasma 
(nmol/l)
Blood plasma 
(pg/ml)
(1st group) Patients 
with psychotropic 
drug-induced 
nephropathy
1.13 ± 0.71 14.93 ± 2.66* 0.312 ± 0.086* 332.2 ± 112*
(2nd group) Patients 
with NSAID drug-
induced nephropathy
0.78 ± 1.62 15.81 ± 1.01* 0.301 ± 0.09* 324.17 ± 96*
Control subjects 0.72 ± 0.16 10.76 ± 1.26 0.192 ± 0.052 80.49 ± 85.13
*Reliability of differences with the control group, p<0.01, AOPP: Advanced oxidation protein product, PRCD: 
Protein reactive carbonyl derivatives, NSAID: Nonsteroidal anti-inflammatory drugs, NGAL: Neutrophil 
gelatinase-associated lipocalin, DIP: Drug-induced nephropathies.
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The end glycation products are one of the factors of 
post-translational modification of proteins. They can 
also have an effect on the cell at the level of gene 
expression binding to specific cell surface receptors 
(RAGEs) that lead to phosphorylation of mitogen-
activated protein kinases, activation of NF-κB, 
and secretion of pro-inflammatory cytokines [15]. 
Macrophage-mediated cell infiltration initiates AOPP 
production, exacerbating the course of nephropathy.
A pronounced increase of carbonyl derivatives, 
AOPP in patients with psychotropic drug-induced 
nephropathy and in patients with nephropathy caused 
by NSAIDs, may underlie specific mechanisms.
NSAIDs-induced nephrotoxicity is realized 
through several mechanisms of cell death. It has been 
established that drugs with the properties of acids 
(nitrosalicylic acid, acetylsalicylic acid, diclofenac, 
naproxen, ibuprofen, indomethacin, piroxicam, etc.) 
can inhibit mitochondrial oxidative phosphorylation2. 
In renal tubules, favorable conditions are created 
for the inhibitory effect of NSAIDs on oxidative 
phosphorylation. The uncoupling of oxidative 
phosphorylation and the loss of ATP leads to the 
disturbance of cellular ion homeostasis, namely, to 
the decrease of intracellular K + content and to the 
increase of Na + content that results in membrane 
depolarization and cell death. The disturbance of 
energy-dependent calcium homeostasis is also 
associated with the increased content of free Ca2 + in 
cytosol that plays a critical role in cell death [2].
Another nephrotoxicity mechanism of NSAIDs 
is associated with the formation of active metabolites. 
With the participation of cytochrome P-450 (mainly its 
isoform CYP2E1), the electrophilic intermediates are 
formed which, covalently bind to cell macromolecules, 
disrupting mitochondrial, and nuclear functions, 
thereby triggering ROS production, protein oxidation, 
and PRCD formation in erythrocytes. In patients with 
chronic kidney disease of the 1-2 stage, the carbonyl 
derivatives level in erythrocytes was in 3 times lower 
than in the control group. It can be explained by the 
conformation of the oxidized proteins and exposure 
of hydrophobic parts to the outside during the 
excessive PRCD formation, which creates conditions 
for the formation of protein-protein conglomerates 
and insoluble protein aggregates and causes the 
progression of nephropathy [12], [21].
In addition, when taking NSAIDs, an 
immunoallergic reaction can be developed which is 
characterized by macrophage interstitial infiltration – 
the main producers of ROS and nitric oxide [2], whose 
targets are tyrosine residues in proteins, cytochromes, 
and myeloperoxidase, that is confirmed by the high level 
of AOPP in these patients. Each of the above mediators 
has a direct cytotoxic effect or is able to enhance the 
inflammatory response of tissues to other damaging 
factors.
Conclusion
Thus, the results of the present study permit 
us to draw the following conclusions. The patients with 
psychotropic and NSAIDs drug-induced nephropathy 
have increased level of oxidative stress products 
and increased NGAL level even in normal eGFR. 
The mechanisms that lead to the development of 
oxidative stress and the production of modified proteins 
are different in patients treated with different drugs. 
Establishing patterns of cell-molecular interaction 
permit the drug-induced nephropathy to be timely 
diagnosed and therapeutic programs to be optimized.
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